Ryan Borrowman, NP
Family · St George, UTNPI 1487001442
Payments from drug & device makers
Across 120 payments — averaging $17.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$521
- Pfizer$283
- Lilly USA, LLC$158
- Biohaven Pharmaceutical Holding Company Ltd.$152
- Johnson & Johnson$129
- Boehringer Ingelheim$113
- plus $729 from 22 others
What the payments were for
- Food & beverage$1,99996%
- Education$854%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 37 | $521 |
| Pfizer | 17 | $283 |
| Lilly USA, LLC | 10 | $158 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $152 |
| Johnson & Johnson | 3 | $129 |
| Boehringer Ingelheim | 8 | $113 |
| Astellas Pharma US Inc | 1 | $85 |
| Indivior Inc. | 2 | $63 |
| AstraZeneca | 4 | $58 |
| Amgen | 3 | $49 |
| Lucid Diagnostics Inc. | 2 | $44 |
| Exact Sciences | 2 | $44 |
| Lundbeck LLC | 2 | $40 |
| Biohaven Pharmaceuticals, Inc. | 3 | $40 |
| Nevro Corp. | 1 | $36 |
| Idorsia Pharmaceuticals US Inc | 2 | $35 |
| Boston Scientific | 1 | $35 |
| Medtronic | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Radius Health, Inc. | 1 | $21 |
| Abiomed | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Halozyme Inc | 1 | $18 |
| Antares Pharma, Inc. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
| Merck | 1 | $14 |
| GSK | 1 | $12 |
| Novo Nordisk | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$104
How this compares
$2,084 in reported general payments places this provider in the 80th percentile of 1,460 family providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 71 | $123,362 |
| JardianceEmpagliflozin | 78 | $117,149 |
| EliquisApixaban | 74 | $74,811 |
| JanuviaSitagliptin Phosphate | 27 | $39,974 |
| XareltoRivaroxaban | 26 | $31,761 |
| TrulicityDulaglutide | 17 | $22,141 |
| MyrbetriqMirabegron | 24 | $18,653 |
| MounjaroTirzepatide | 17 | $17,422 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $13,411 |
| Omeprazole | 371 | $7,147 |
| Gabapentin | 142 | $4,673 |
| Levothyroxine Sodium | 348 | $4,535 |
| Atorvastatin Calcium | 361 | $4,287 |
| Testosterone Cypionate | 84 | $4,225 |
| Celecoxib | 130 | $3,825 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $12 | $123,36271 claims |
| Boehringer IngelheimJardiance | $113 | $117,14978 claims |
| PfizerEliquis | $283 | $74,81174 claims |
| MerckJanuvia | $14 | $39,97427 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $158 | $39,56334 claims |
| Johnson & JohnsonXarelto | $129 | $31,76126 claims |
| Astellas Pharma US IncMyrbetriq | $85 | $18,65324 claims |
| AstraZenecaBreztri Aerosphere | $58 | $13,41112 claims |
| AbbVieArmour Thyroid | $521 | $1,58714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,460 family providers in Utah.
Other family in St George
- Allie BlazzardSt George$44K
- Kelsie MontgomerySt George$15K
- Ashlee WalkerSt George$8K
- Michelle BallardSt George$8K
- Amanda TurnerSt George$8K
- Riley WorthSandy$1.1M
- Katrina BawdenSalt Lake City$446K
- Cortnee RomanSalt Lake City$374K
- Jared ThorleySalt Lake City$368K
- Stephanie GodfreyLindon$358K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.